Quest Diagnostics Launches AI Tool to Help Patients Interpret Lab Results
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
Latest Articles
Editor's Top Picks
Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses
The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Labcorp Deploys AI-Powered Digital Pathology Platform Across National Network
Labcorp is expanding its partnership with PathAI to deploy the FDA-cleared AISight Dx digital pathology platform across its national network, enabling fully digital workflows and AI-supported diagnostics in anatomic pathology labs.
Equipment & Supply Spotlight
ADLM Pushes for Updated Lab Regulations as AI Use Expands
The Association for Diagnostics & Laboratory Medicine is urging Congress and federal agencies to update regulations to address AI bias in clinical lab systems, citing risks to marginalized patient groups from models trained on limited data.
News, Know-How & Standards
Disease Detection & Understanding
Veracyte Presents 15 Studies on Decipher Cancer Tests at ASCO GU Symposium
Veracyte will present over 15 studies on its Decipher prostate and bladder cancer tests, including new clinical trial data, at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco.
